331 related articles for article (PubMed ID: 20200938)
1. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
Hokugo A; Christensen R; Chung EM; Sung EC; Felsenfeld AL; Sayre JW; Garrett N; Adams JS; Nishimura I
J Bone Miner Res; 2010 Jun; 25(6):1337-49. PubMed ID: 20200938
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
[TBL] [Abstract][Full Text] [Related]
3. Histopathological features of bisphosphonates related osteonecrosis of the jaw in rats with and without vitamin d supplementation.
Yanık S; Aras MH; Erkılıç S; Bozdağ Z; Demir T; Çetiner S
Arch Oral Biol; 2016 May; 65():59-65. PubMed ID: 26854621
[TBL] [Abstract][Full Text] [Related]
4. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
[TBL] [Abstract][Full Text] [Related]
5. Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.
Aguirre JI; Akhter MP; Kimmel DB; Pingel JE; Williams A; Jorgensen M; Kesavalu L; Wronski TJ
J Bone Miner Res; 2012 Oct; 27(10):2130-43. PubMed ID: 22623376
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
[TBL] [Abstract][Full Text] [Related]
7. Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease.
Kim JW; Tatad JCI; Landayan MEA; Kim SJ; Kim MR
Bone; 2015 Dec; 81():442-448. PubMed ID: 26297440
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate induces osteonecrosis of the jaw in sheep.
Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
[TBL] [Abstract][Full Text] [Related]
9. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the jaw and the role of macrophages.
Pazianas M
J Natl Cancer Inst; 2011 Feb; 103(3):232-40. PubMed ID: 21189409
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
[TBL] [Abstract][Full Text] [Related]
13. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis of the jaw: who gets it, and why?
Reid IR
Bone; 2009 Jan; 44(1):4-10. PubMed ID: 18948230
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model.
Ogata K; Katagiri W; Osugi M; Kawai T; Sugimura Y; Hibi H; Nakamura S; Ueda M
Bone; 2015 May; 74():95-105. PubMed ID: 25613174
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?
Lesclous P; Abi Najm S; Carrel JP; Baroukh B; Lombardi T; Willi JP; Rizzoli R; Saffar JL; Samson J
Bone; 2009 Nov; 45(5):843-52. PubMed ID: 19631301
[TBL] [Abstract][Full Text] [Related]
17. Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.
Williams DW; Lee C; Kim T; Yagita H; Wu H; Park S; Yang P; Liu H; Shi S; Shin KH; Kang MK; Park NH; Kim RH
Am J Pathol; 2014 Nov; 184(11):3084-93. PubMed ID: 25173134
[TBL] [Abstract][Full Text] [Related]
18. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
Mavrokokki T; Cheng A; Stein B; Goss A
J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics.
Soma T; Iwasaki R; Sato Y; Kobayashi T; Ito E; Matsumoto T; Kimura A; Miyamoto K; Matsumoto M; Nakamura M; Morita M; Asoda S; Kawana H; Nakagawa T; Miyamoto T
Sci Rep; 2022 Jan; 12(1):19. PubMed ID: 34997043
[TBL] [Abstract][Full Text] [Related]
20. Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw.
Kim JW; Landayan ME; Lee JY; Tatad JC; Kim SJ; Kim MR; Cha IH
Clin Oral Investig; 2016 Nov; 20(8):2251-2258. PubMed ID: 26795624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
